Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.66 |
| ▸ | GLA | P06280 | 1/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.48 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | SNCA | P37840 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | XDH | P47989 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA4 | P22748 | 2/20 | 0.35 |
| ▸ | CA5A | P35218 | 2/20 | 0.35 |
| ▸ | CA7 | P43166 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6847752 | 0.94 | ALDH1A1 (0.88) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| SCHEMBL29425763 | 0.89 | ALDH1A1 (0.80) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| SCHEMBL29425887 | 0.84 | ALDH1A1 (0.71) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| SCHEMBL29208523 | 0.84 | ALDH1A1 (0.71) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| SCHEMBL29727271 | 0.84 | ALDH1A1 (0.71) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| SCHEMBL24278467 | 0.83 | ALDH1A1 (0.71) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| SCHEMBL23720483 | 0.83 | ALDH1A1 (0.71) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| SCHEMBL30089774 | 0.83 | ALDH1A1 (0.71) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| SCHEMBL14011094 | 0.82 | ALDH1A1 (0.70) | ALDH1A1TSHRKDM4EGLACYP3A4 | |
| SCHEMBL25271744 | 0.81 | ALDH1A1 (0.67) | ALDH1A1TSHRKDM4EGLACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1063 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118209664-B | Feature map construction method, quality control method and preparation method of Simiaoyangan Shang Jizhun sample | 桂林三金药业股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122056901-A | Pharmaceutical application of harpagoside | 金陵药业股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122056902-A | Pharmaceutical application of harpagoside | 金陵药业股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-12595220-B2 | Cocrystals of pterostilbene and compositions comprising them | CENTER FOR INTELLIGENT RESEARCH IN CRYSTAL ENGINEERING, S.L. (ES) | 2026-04-07 | — | — | US | claimed |
| EP-4077258-B1 | COCRYSTALS OF PTEROSTILBENE AND COMPOSITIONS COMPRISING THEM | CENTER FOR INTELLIGENT RES IN CRYSTAL ENGINEERING S L (ES) | 2026-03-25 | — | — | EP | claimed |
| US-20260007713-A1 | LIANG DI TANG WATER-EXTRACTED LIQUID, LIANG DI TANG WATER-EXTRACTED PASTE, AND LIANG DI TANG PREPARATION, AND PREPARATION METHODS THEREOF, AND QUALITY CONTROL STANDARD FOR LIANG DI TANG PREPARATION | DONG-E-E-JIAO CO., LTD. (CN) | 2026-01-08 | — | — | US | claimed |
| US-20250352602-A1 | DIETARY SUPPLEMENTS AND METHODS FOR REDUCING INFLAMMATION | MELALEUCA INC (US) | 2025-11-20 | — | — | US | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| EP-4595968-A1 | REHMANNIA AND LYCIUM ROOT BARK DECOCTION WATER EXTRACT SOLUTION, REHMANNIA AND LYCIUM ROOT BARK DECOCTION WATER EXTRACT PASTE, REHMANNIA AND LYCIUM ROOT BARK DECOCTION PREPARATION AND PREPARATION METHOD THEREFOR, AND QUALITY CONTROL STANDARD FOR REHMANNIA AND LYCIUM ROOT BARK DECOCTION PREPARATION | Dong-e E-jiao Co., Ltd. (CN) | 2025-08-06 | — | — | EP | claimed |
| CN-120195297-A | Fingerprint detection method of yellow land yin nourishing particles | 辽宁沃华康辰医药有限公司 | 2025-06-24 | — | — | CN | claimed |
| EP-1210945-B1 | Pharmaceutical composition with antiarteriosclerotic activity | SALUS HAUS GMBH & CO KG (DE) | 2006-05-10 | — | — | EP | claimed |
| US-20060074108-A1 | Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition | BIODERM RESEARCH (US) | 2006-04-06 | — | — | US | claimed |
| US-20050271608-A1 | Skin whitening compositions based on hydroxyaryl alkyl ketones and their isosteric derivatives | GUPTA SHYAM K | 2005-12-08 | — | — | US | claimed |
| CN-1679648-A | Mailuoning injection and its preparation and quality control | QIYUANYIDE MEDICAL INST BEIJIN (CN) | 2005-10-12 | — | — | CN | claimed |
| US-6395308-B1 | FOR THE TREATMENT OF ASTHMA BRONCHIALE, COLITIS ULCEROSA, MORBUS CROHN, DISEASES OF THE RHEUMATIC TYPE, AND INDICATIONS IN WHICH AN INCREASE OF THE LIPOXYGENASE LEVEL OCCURS EITHER BY MEDICAMENTS, OTHER SUBSTANCES OR DISEASES. | FINZEKBERG GMBH & CO. KG (DE) | 2002-05-28 | — | — | US | claimed |
| US-6280737-B1 | DRUG EXTRACT OBTAINED BY EXTRACTING PLANT ROOTS WITH WATER OR MIXTURE OF ETHANOL AND WATER, CONCENTRATING, STIRRING WITH ALIPHATIC ALCOHOL AND/OR ALIPHATIC KETONE, SEPARATING INSOLUBLE FRACTION FROM OBTAINED SOLUBLE FRACTION | DR. WILLMAR SCHWABE GMBH & CO. (DE) | 2001-08-28 | — | — | US | claimed |
| US-6197307-B1 | EXTRACTING WITH SUB- OR SUPERCRITICAL CARBON DIOXIDE AND COSOLVENT, ALLOWING CARBON DIOXIDE TO EVAPORATE | ESSENTIAL NUTRITION, LTD. (GB) | 2001-03-06 | — | — | US | claimed |
| US-5929038-A | ADMINISTERING IRIDOID COMPOUNDS | CHOONGWAE PHARMACEUTICAL CO., LTD. (KR) | 1999-07-27 | — | — | US | claimed |
| EP-0897302-B1 | HARPAGOSIDE-ENRICHED EXTRACT FROM HARPAGOPHYTUM PROCUMBENS AND PROCESSES FOR PRODUCING SAME | SCHWABE WILLMAR GMBH & CO (DE) | 1999-06-23 | — | — | EP | claimed |
| WO-1999007329-A1 | DENTAL CEMENT COMPOSITIONS AND DENTAL FIRST AID KIT COMPRISING SAME | HADDAD LAURENT (FR) | 1999-02-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007713-A1 | LIANG DI TANG WATER-EXTRACTED LIQUID, LIANG DI TANG WATER-EXTRACTED PASTE, AND LIANG DI TANG PREPARATION, AND PREPARATION METHODS THEREOF, AND QUALITY CONTROL STANDARD FOR LIANG DI TANG PREPARATION | AQP4, AQP3, SORD | ALDH1A1 3241/4885TSHR 3825/4885KDM4E 1976/4885 |
| US-12595220-B2 | Cocrystals of pterostilbene and compositions comprising them | SHBG, PSEN1, SREBF1 | ALDH1A1 3978/4885TSHR 1543/4885KDM4E 3858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.